Dr. Daniel L. Payne, MD

Dr. Payne practices at Wk Louisiana Family Practice in Bossier City, Louisiana.

Dr. Payne's NPI, 1073557542, was assigned on June 15, 2006. Dr. Payne graduated from Louisiana State University School of Medicine in Shreveport in 1992. Dr. Payne holds Louisiana license 021626.

Dr. Payne's primary practice is Wk Louisiana Family Practice, at 2300 Hospital Dr Suite 200 Suite 200, Bossier City, LA 71111-2169. The practice phone is (318) 212-7830.

Dr. Payne's primary practice is Wk Louisiana Family Practice in Bossier City, Louisiana. Dr. Payne is also affiliated with Willis Knighton North. The medical group on file is Willis Knighton Louisiana Family Practice. Dmand AI also links Dr. Payne to 1 more hospital and 4 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Payne practices, 7 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Payne's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Payne is licensed in Louisiana.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, aneurysm, arthritis, asthma, atrial fibrillation and flutter and bronchitis among the conditions Dr. Payne treats.

CMS data shows 2,035 Medicare services from Dr. Payne across 18 procedure codes in 2024, for 301 Medicare patients. Medicare paid $65,146 for them. Every service was in an office.

CMS counts 301 Medicare patients who saw Dr. Payne in 2024. The largest group is 65 to 74, with 155 patients. 75% of them have high blood pressure, and 65% have high cholesterol. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Payne's median patient age at 63, with 45% women.

In 2024, Dr. Payne wrote 7,893 Medicare Part D claims for 399 patients. 86% of them were for generic drugs. CMS names the drug for 7,168 of them, across 129 drugs with 11 or more claims each, at $619,454 in total drug cost. In 2023, CMS named 6,847 claims across 129 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Payne for performance year 2024, reported through an alternative payment model (APM). Dr. Payne accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 26 procedures of removal of skin lesions by Dr. Payne, more than 67% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Payne, published from 2020 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Hemoglobinuria, Paroxysmal, Anemia, Aplastic and COVID-19. Dr. Payne has published most often in Cytometry B Clin Cytom. Dr. Payne's most frequent co-author is Stephen J. Richards, MD.

CMS Open Payments shows 950 general payments to Dr. Payne from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,947.

Dr. Payne graduated from Louisiana State University School of Medicine in Shreveport in 1992.

Dr. Payne is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.